Bio-Rad Laboratories (BIO) Debt to Equity (2009 - 2026)

Bio-Rad Laboratories (BIO) reported Debt to Equity of $0.12 for Q1 2026, down 34.81% year-over-year from $0.18 in Q1 2025, and down 27.31% quarter-over-quarter from $0.16 in Q4 2025.

Bio-Rad Laboratories (BIO) Debt to Equity (2009 - 2026) Analysis & Trends

Bio-Rad Laboratories (BIO) has 18 years of Debt to Equity data on file, last reported at $0.12 in Q1 2026.

  • Debt to Equity for Q1 2026 came in at $0.12, down 34.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.12 (down 34.81% YoY), and the FY2025 annual result was $0.16, down 11.77% from the prior year.
  • Debt to Equity slipped to $0.12 in Q1 2026 per BIO's latest filing, from $0.16 in the prior quarter.
  • Over five years, Debt to Equity peaked at $0.18 in Q4 2024 and troughed at $0.12 in Q1 2026.
  • A 5-year average of $0.15 and a median of $0.14 in 2023 frame the typical range for Debt to Equity.
  • The sharpest annual moves came in 2022 and 2026: Debt to Equity surged 20241.86% in 2022, then tumbled 34.81% in 2026.
  • A 5-year view of Debt to Equity shows it stood at $0.12 in 2022, then increased by 10.13% to $0.14 in 2023, then soared by 33.21% to $0.18 in 2024, then retreated by 11.77% to $0.16 in 2025, then fell by 27.31% to $0.12 in 2026.
  • Business Quant data shows BIO's Debt to Equity at $0.12 in Q1 2026, $0.16 in Q4 2025, and $0.18 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 0.65
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 0.64
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 0.57
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 0.42
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 0.06
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.71
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 0.95
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 0.27
10 Bio-Rad Laboratories 7.62 Bn 6.05 Bn 309.40 Mn 0.12

Historic Data

Download Data
DateValue
Mar 31, 2026 0.12
Dec 31, 2025 0.16
Sep 30, 2025 0.18
Jun 30, 2025 0.17
Mar 31, 2025 0.18
Dec 31, 2024 0.18
Sep 30, 2024 0.16
Jun 30, 2024 0.18
Mar 31, 2024 0.13
Dec 31, 2023 0.14
Sep 30, 2023 0.14
Jun 30, 2023 0.14
Mar 31, 2023 0.12
Dec 31, 2022 0.12
Sep 30, 2022 0.14
Jun 30, 2022 0.13
Mar 31, 2022 0.12
Dec 31, 2021 0.00
Sep 30, 2021 0.00
Jun 30, 2021 0.00